The Pharma Letter9d
FDA removes heart risk warning from testosterone products
The US Food and Drug Administration has issued new labeling changes for all approved testosterone replacement therapy ...
Marius Pharmaceuticals Helps Drive FDA’s Landmark Testosterone Label Update, Removing Black Box Warning
The TRAVERSE trial, a large-scale clinical study with over 5,000 patients, published in 2023, concluded that TRT does not increase the risk of adverse cardiovascular outcomes in men with hypogonadism.
US FDA issues labeling changes for testosterone products
The U.S. Food and Drug Administration said on Friday it issued new labeling changes for testosterone products based on ...
Yahoo Finance1mon
Marius Pharmaceuticals Announces KYZATREX® (testosterone undecanoate) CIII Capsules Availability Through Thrive, Expanding Men's Health Solutions
About Marius Pharmaceuticals ... or Testosterone Deficiency. The company's vision is to holistically improve metabolic health and mitigate significant unnecessary costs to the global healthcare ...
Hosted on MSN2mon
Global testosterone replacement therapy market to rise by $461m by 2029
Its growth is driven by a rising awareness of hypogonadism. The global testosterone replacement therapy (TRT) market is projected to grow by $461m by 2029 at a compound annual growth rate of 3.3% ...
Marius Pharmaceuticals Partners with Major Academic Medical Center on Education and Research Efforts for Oral Testosterone
Marius Pharmaceuticals, a pharmaceutical company dedicated to developing innovative therapies for testosterone deficiency, has partnered with Duke University School of Medicine to explore the ...
Yahoo Finance10d
Marius Pharmaceuticals Helps Drive FDA’s Landmark Testosterone Label Update, Removing Black Box Warning
In September 2024, Marius Pharmaceuticals proactively submitted ... has reaffirmed the safety and benefits of testosterone therapy. A global consensus has emerged on testosterone’s ...
Yahoo Finance1mon
Marius Pharmaceuticals Announces KYZATREX® (testosterone undecanoate) CIII Capsules Availability Through Thrive, Expanding Men's Health Solutions
RALEIGH, N.C., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals ... hypogonadism or Testosterone Deficiency. The company's vision is to holistically improve metabolic health and mitigate ...